Dr Vytenis Andriukaitis, EU Commissioner for Health and Food Safety, visited the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) to inform himself about multidrug-resistant pathogens
In 2016, a clinical phase I trial on a potential vaccine against the dreaded Ebola virus was successfully completed. The tested vaccine “rVSV-ZEBOV” proved to be safe and effective. In a further trial
This year, the Memento Research Award for neglected diseases goes to Dr Carsten Köhler and Prof Peter Kremsner from the Institute of Tropical Diseases at the University Hospital Tübingen. With this
Researchers of the University of Tübingen and DZIF in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria® PfSPZ
Almost everybody has it: Scientists estimate that approximately 98 percent of adults around the world are infected with the Epstein-Barr virus. In rare cases, an infection with this virus causes
An international team of scientists has sequenced the genomes of two rare malaria pathogens, both parasites of the plasmodium species. A scientist from the Bernhard Nocht Institute for Tropical
The recent Ebola crisis has triggered global rethinking: the global community wants to be better prepared for serious infectious disease epidemics than before. For this purpose, the international
A research team led by investigators of the Rockefeller University in New York and Prof Florian Klein, University Hospital Cologne and German Center for Infection Research (DZIF), has tested a new HIV
In laboratory experiments, scientists at the Bernhard Nocht Institute for Tropical Medicine (BNITM) and the DZIF have confirmed that some specimens of the Asian tiger mosquito Aedes albopictus that
Scientists from the German Center for Infection Research (DZIF) are on a specific quest for the causes of and biomarkers for severe courses of Pfeiffer’s disease. The disease is caused by the Epstein
